100 related articles for article (PubMed ID: 1725537)
41. Creatinol O-phosphate therapy in patients with inadequate coronary circulation. Double-blind clinical trial.
Barlattani M; Guglielmi G; Mammarella A
Arzneimittelforschung; 1979; 29(9a):1483-5. PubMed ID: 395958
[TBL] [Abstract][Full Text] [Related]
42. Frequent episodes of silent myocardial ischemia after apparently uncomplicated myocardial infarction.
Cohn PF; Sodums MT; Lawson WE; Vlay SC; Brown EJ
J Am Coll Cardiol; 1986 Oct; 8(4):982-5. PubMed ID: 3760372
[TBL] [Abstract][Full Text] [Related]
43. The effects of diltiazem on cardiac function in silent ischemia after myocardial infarction.
van der Wall EE; Cats VM; Blokland JA; Bosker HA; Arndt JW; Pauwels EK; Bruschke AV
Am Heart J; 1989 Oct; 118(4):655-61. PubMed ID: 2801473
[TBL] [Abstract][Full Text] [Related]
44. Rewards in practice from chrono-meta-analyses 'recycling' heart rate, ectopy, ischemia and blood pressure information.
Halberg F; Cornélissen G; Otsuka K; Watanabe Y; Wood MA; Lambert CR; Zaslavskaya R; Gubin D; Yuryevna Petukhova E; Delmore P; Bakken E
J Med Eng Technol; 1997; 21(5):174-84. PubMed ID: 9350598
[TBL] [Abstract][Full Text] [Related]
45. Time-series analysis of long-term ambulatory myocardial ischemia: effects of beta-adrenergic and calcium channel blockade.
Lambert CR; Raymenants E; Pepine CJ
Am Heart J; 1995 Apr; 129(4):677-84. PubMed ID: 7900617
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of dipyridamole-induced myocardial ischemia by diltiazem in patients with coronary artery disease.
Kubota I; Ikeda K; Igarashi H; Kawashima S; Yamaki M; Yasumura S; Tsuiki K; Yasui S
J Cardiovasc Pharmacol; 1987 Mar; 9(3):363-7. PubMed ID: 2437403
[TBL] [Abstract][Full Text] [Related]
47. Improvement of silent myocardial ischaemia and reduction of plasma fibrinogen during nisoldipine therapy in occult coronary arterial disease.
Salmasi AM; Salmasi S; MacDonald G; Nicolaides AN
Int J Cardiol; 1991 Apr; 31(1):71-80. PubMed ID: 2071252
[TBL] [Abstract][Full Text] [Related]
48. The prognostic and economic implications of a strategy to detect and treat asymptomatic ischemia: the Atenolol Silent Ischemia Trial (ASIST) protocol.
Pepine CJ; Cohn PF; Deedwania PC; Gibson RS; Gottlieb SO; Handberg E; Hill JA
Clin Cardiol; 1991 Jun; 14(6):457-62. PubMed ID: 1810681
[TBL] [Abstract][Full Text] [Related]
49. Frequency and significance of early postoperative silent myocardial ischemia in patients having peripheral vascular surgery.
Ouyang P; Gerstenblith G; Furman WR; Golueke PJ; Gottlieb SO
Am J Cardiol; 1989 Nov; 64(18):1113-6. PubMed ID: 2816764
[TBL] [Abstract][Full Text] [Related]
50. Role of adenosine and opioid-receptor mechanisms for pain in patients with silent myocardial ischemia or angina pectoris: a double-blind, placebo-controlled study.
Sadigh-Lindell B; Sylvén C; Berglund M; Eriksson BE
J Cardiovasc Pharmacol; 2003 Dec; 42(6):757-63. PubMed ID: 14639098
[TBL] [Abstract][Full Text] [Related]
51. Myocardial ischemia during cocaine withdrawal.
Nademanee K; Gorelick DA; Josephson MA; Ryan MA; Wilkins JN; Robertson HA; Mody FV; Intarachot V
Ann Intern Med; 1989 Dec; 111(11):876-80. PubMed ID: 2817640
[TBL] [Abstract][Full Text] [Related]
52. An update to silent myocardial ischemia: pathophysiological, diagnostic, and therapeutic approaches.
Fu LX; Hjalmarson A
Clin Cardiol; 1990 Jul; 13(7):452-6. PubMed ID: 1973087
[TBL] [Abstract][Full Text] [Related]
53. [Prevention of per- and postoperative myocardial ischemia in non-cardiac surgery by intravenous diltiazem].
Caramella JP; Goursot G; Carcone B; Desmonts JM; Fargnoli JM; Marty J; Cazor JL; Elkik F
Ann Fr Anesth Reanim; 1988; 7(3):245-50. PubMed ID: 3408038
[TBL] [Abstract][Full Text] [Related]
54. Rationale for treatment of silent myocardial ischemia: focus on nifedipine.
Nesto RW
Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():929-34. PubMed ID: 2076402
[TBL] [Abstract][Full Text] [Related]
55. Asymptomatic Cardiac Ischemia Pilot study (ACIP).
Am J Cardiol; 1992 Sep; 70(7):744-7. PubMed ID: 1519524
[TBL] [Abstract][Full Text] [Related]
56. Effect of diltiazem on cardiac rate and rhythm after myocardial infarction. Multicenter Diltiazem Postinfarction Trial Investigators.
Bigger JT; Coromilas J; Rolnitzky LM; Fleiss JL; Kleiger RE
Am J Cardiol; 1990 Mar; 65(9):539-46. PubMed ID: 2178379
[TBL] [Abstract][Full Text] [Related]
57. [Characteristics of dilzem treatment of patients with ischemic heart disease].
Zharov EI; Styrova TK; Martynov AI; Barinov VG; Makarovskiĭ VV; Vertkin AL; Sedov VP; Galichenko IV
Kardiologiia; 1990 Dec; 30(12):30-3. PubMed ID: 2097392
[TBL] [Abstract][Full Text] [Related]
58. Use of intravenous diltiazem in patients with acute coronary artery disease.
Jaffe AS
Am J Cardiol; 1992 Mar; 69(7):25B-29B. PubMed ID: 1543138
[TBL] [Abstract][Full Text] [Related]
59. Can we really justify the treatment of silent ischemia in 1992? No!
Mulcahy D; Fox K
Cardiovasc Drugs Ther; 1992 Apr; 6(2):125-9. PubMed ID: 1390322
[TBL] [Abstract][Full Text] [Related]
60. Silent ischemia: to treat or not.
Shell WE
Am Heart J; 1990 Sep; 120(3):766-8; discussion 769-72. PubMed ID: 2117847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
